换一批Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial
关键词
advanced basal cell carcinomaadverse eventsalopeciabasal cell carcinomabasal cell carcinoma histopathologycancerdysgeusiaHedgehog pathway inhibitorhigh risk basal cell carcinomahistologic clearancehistologic featureshistopathologic subtype of basal cell carcinomahistopathologyinfiltrativelocally advanced basal cell carcinomamuscle spasmsnodularsafetyshort course therapyshort-term therapysuperficialtolerabilitytumor responsevismodegib
发布时间
2020-06-23
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
